

#1873 - Brigham Buhler
41 snips Sep 23, 2022
Brigham Buhler, founder of Ways2Well and ReviveRx, discusses the transformative potential of regenerative medicine and stem cell therapies. He shares personal anecdotes about his journey from pharmaceutical sales to advocating for patient-centered care. The conversation delves into the shift from personalized medicine to profit-driven healthcare, emphasizing the need for ethical practices. Buhler also highlights the importance of hormone optimization and innovative treatments like peptides, advocating for a holistic approach to health and wellness.
AI Snips
Chapters
Transcript
Episode notes
Early Drug Rep Experience
- Brigham Buhler, as a young drug rep, had a $17,000 monthly expense account to promote Cialis.
- This encouraged lavish dinners with doctors and highlighted the pharmaceutical industry's focus on sales over clinical expertise.
Shift in Pharma Hiring
- Pharmaceutical companies shifted from hiring clinical experts to attractive salespeople.
- This change aimed to influence busy doctors who had limited time for in-depth scientific discussions.
Limited Doctor-Patient Time
- Insurance-based models give doctors limited time with patients, about seven minutes on average.
- This time constraint hinders patient care and forces quick diagnoses and treatments, not root cause analysis.